- Home
- RPRX vs PAA Comparison
RPRX vs PAA Comparison
Compare RPRX & PAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- PAA
- Stock Information
- Founded
- RPRX 1996
- PAA 1981
- Country
- RPRX United States
- PAA United States
- Employees
- RPRX N/A
- PAA N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- PAA Natural Gas Distribution
- Sector
- RPRX Health Care
- PAA Energy
- Exchange
- RPRX Nasdaq
- PAA Nasdaq
- Market Cap
- RPRX 14.2B
- PAA 13.6B
- IPO Year
- RPRX 2020
- PAA N/A
- Fundamental
- Price
- RPRX $31.28
- PAA $20.28
- Analyst Decision
- RPRX Strong Buy
- PAA Buy
- Analyst Count
- RPRX 5
- PAA 13
- Target Price
- RPRX $41.60
- PAA $20.92
- AVG Volume (30 Days)
- RPRX 4.5M
- PAA 3.1M
- Earning Date
- RPRX 05-08-2025
- PAA 05-02-2025
- Dividend Yield
- RPRX 2.81%
- PAA 7.50%
- EPS Growth
- RPRX N/A
- PAA N/A
- EPS
- RPRX 1.91
- PAA 0.73
- Revenue
- RPRX $2,263,576,000.00
- PAA $50,073,000,000.00
- Revenue This Year
- RPRX $34.04
- PAA $12.76
- Revenue Next Year
- RPRX $6.10
- PAA N/A
- P/E Ratio
- RPRX $16.36
- PAA $27.70
- Revenue Growth
- RPRX N/A
- PAA 2.79
- 52 Week Low
- RPRX $24.05
- PAA $16.21
- 52 Week High
- RPRX $34.20
- PAA $21.00
- Technical
- Relative Strength Index (RSI)
- RPRX 35.96
- PAA 56.19
- Support Level
- RPRX $30.64
- PAA $19.81
- Resistance Level
- RPRX $31.51
- PAA $20.24
- Average True Range (ATR)
- RPRX 0.74
- PAA 0.33
- MACD
- RPRX -0.31
- PAA 0.02
- Stochastic Oscillator
- RPRX 18.29
- PAA 84.92
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About PAA Plains All American Pipeline L.P.
Plains All American Pipeline LP through its subsidiaries, engages in the pipeline transportation, terminaling, storage, and gathering of crude oil and natural gas liquids (NGL) in the United States and Canada. The company operates through two segments, Crude Oil and NGL. The Crude Oil segment offers gathering and transporting crude oil through pipelines, gathering systems, trucks, and barges or railcars. The NGL segment is involved in natural gas processing and NGL fractionation, storage, transportation, and terminalling. It generates the majority of its revenue from the Crude Oil segment.